• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Switzerland·Healthcare·CLTN.SW
Share

COLTENE Holding AG Stocks

CHF 46.8Last Updated 09.10.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

CHF 337.15M

CHF 46.8
Key Takeaways

Risk factor

Resilient to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Weak growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Headquartered in Altstätten, Switzerland, COLTENE Holding AG, established in 2005 and formerly known as Medisize Holding AG until its name change in April 2008, is a global leader in the development, manufacturing, and sale of a diverse range of consumables, instruments, and equipment specifically designed for dentists and dental laboratories. The company's comprehensive product line addresses various aspects of dental care across Europe, the Middle East, Africa, North America, Latin America, and Asia/Oceania. Key offerings include advanced materials for restorations, such as conventional and bulk-fill composites, CAD/CAM solutions, bonding agents, and curing lights. For endodontic procedures, they provide specialized tools like rotary and hand files, irrigation solutions, and obturation materials. Their prosthetics segment features products for bite registration and impression materials like A-silicones and C-silicones. Additionally, COLTENE supplies essential treatment auxiliaries, including dental rolls, aspirator tips, and dental dams; infection control solutions such as ultrasonic cleaning units and patient bibs; and a variety of rotary instruments, including diamond and carbide burs. The company also offers a full suite of laboratory products, encompassing gingiva masks, model making materials, and specialized burs and polishers.

Company Valuation

Slightly undervalued
5/7

Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EB

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of CLTN.SW is 56.6 and suggests 21% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

13.10.2026 03:00

BofA Identified Three Risks for Apple if SpaceX Becomes a Mobile Carrier

13.10.2026 02:01

Meta launches Muse Wonder AI model, says it has caught up with industry leaders

13.10.2026 01:16

Microsoft could deploy over a million of its own AI chips in 2027, challenging Nvidia

13.10.2026 00:39

Walmart is outperforming luxury stocks. Is that sign of a coming Fed rate cut?

12.10.2026 23:19

LVMH fashion and leather sales disappoint in 3Q due to demand slowdown in China

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026